• Biosynth Carbosynth and Shengquan Acquire New Plant to Increase Production Capacities in China

News

Biosynth Carbosynth and Shengquan Acquire New Plant to Increase Production Capacities in China

Leading life sciences reagents and custom synthesis and manufacturing services company, Biosynth Carbosynth, and Jinan Shengquan Group Share-Holding Co, Ltd have announced their acquisition of Kexing Biopharmaceutical Co, Ltd’s raw material factory in Jinan, China. With this acquisition, Biosynth Carbosynth’s and Shengquan’s joint venture Carbotang expands the production capacities significantly. The more than 30,000 m2 property contains a comprehensive factory building on 5 floors, a demo workshop and a large warehouse including a state-of-the-art dangerous material storage. The expansion through a further production site now allows the group more flexibility and larger production volumes together with an increased production reliability. This is an essential prerequisite in the production of Biosynth Carbosynth’s products.

Dr Urs Spitz, CEO of Biosynth Carbosynth said: “We are delighted to be further expanding our manufacturing operations and hugely successful joint venture. With this strategic acquisition we can continue to deliver our enormous range of products at increasing scales, with unrivalled expertise in complex organic chemistries.”


Digital Edition

ILM 50.3 April 2025

May 2025

Chromatography Articles - Optimising two-step purification: Key considerations for sample pump setups Mass Spectrometry & Spectroscopy Articles - Detecting pharmaceuticals and their transf...

View all digital editions

Events

InformEx Zone at CPhl North America

May 20 2025 Philadelphia, PA, USA

ChemUK 2025

May 21 2025 Birmingham, UK

Future Labs Live Basel 2025

May 27 2025 Basel, Switzerland

ASMS Conference

Jun 01 2025 Baltimore, MD, USA

Chemspec Europe 2025

Jun 04 2025 Koeln, Germany

View all events